Stereotaxis has announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC.
Stereotaxis’ MAGiC catheter is a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures. The first human procedures using the MAGiC catheter were successfully performed by Germanas Marinskis and Gediminas Račkauskas at Vilnius University Hospital Santaros Klinikos in Lithuania. Eight patients were treated in the first week of January, following receipt of approvals to begin enrollment in the prospective clinical trial. Data from the clinical trial will support the CE mark submission of MAGiC.
“We were delighted to perform the first procedures using the MAGiC catheter, and were pleased with the performance,” said Račkauskas. “The catheter was very stable, effective and safe. We look forward to continued enrollment in the coming weeks. The electrophysiology community has long awaited innovation in robotic catheter technology and we are excited to support this progress.”
“This is a significant milestone for Stereotaxis as we advance our comprehensive innovation strategy,” said David Fischel, Stereotaxis chairman and CEO. “We look forward to the impact MAGiC, a key pillar in our new product ecosystem, will have on patients, physicians, and the advancement of medicine.”
